Home › Market News › middle.news

InFocus and Orcoda Rally While Funding Tests Weigh on Smaller Tech Stocks

MARKET NEWS By Logan Eniac 6 min read

Online gaming and workforce software stocks led the week, while several companies fell despite better operating news.
Investors still want proof that new contracts, funding and product launches can produce lasting cash.

  • InFocus rose 28.57% after extending Codexa into licensed online gambling markets outside the US.
  • Orcoda gained 14.58% as Wellcamp workforce volumes increased towards 1,000 workers a day.
  • TZ Limited fell 13.33% while it sought $1.3 million for debt and vendor payments.
  • Nuix returned to profit, but legal issues and a planned $5 million restructure remain.
  • RocketBoots began US store installations under a contract that could produce about A$9.1 million in yearly recurring revenue.

InFocus led the technology group with 28.57% after taking Codexa beyond US sweepstakes gaming. Orcoda followed with 14.58% as its Wellcamp workforce volumes grew. TZ Limited was the weakest of the three biggest movers, falling 13.33% while it looked for money to meet $1.3 million of debt and vendor obligations.

New markets bring new tests

InFocus is targeting licensed gambling operators in Curaçao and crypto-based gaming businesses. Commercial availability is planned for early 2027. The company must still test the product, register as a supplier and win customers. Investors bought the shares after seeing a larger possible customer base. No revenue forecast has been provided.

Orcoda’s rise had a clearer operating reason. Its Wagner and Wellcamp agreement produced about $2.35 million in revenue during the September quarter. Daily workforce volumes are moving from as many as 750 people towards 1,000. The three-year contract remains in place. The company did not disclose the value of a contract change.

Both stocks opened with large price gaps and then kept moving higher. In plain terms, early buyers did not quickly sell those gains. DorsaVi showed the opposite pattern. Its shares reopened at $0.024, then fell 8.33% from that level. The full weekly fall was 12.00%. The company raised A$3 million for humanoid robotics data, defence work and resistive RAM chips. However, its commercial opportunities remain at the partner-testing stage.

Better results do not remove every concern

Nuix returned to a statutory profit of $16.4 million, while revenue rose 18.8% to $263.2 million. Its Nuix Neo software produced annual contract value of $78.5 million, up 179%. Annual contract value is the money expected from customer contracts over a year. Cash flow also rose 154% to $51 million. The shares still fell 11.92% for the week because investors must weigh a planned $5 million restructure, an insurance provision and unresolved legal cases.

Elsewhere, hipages lifted free cash flow by 66% to $9.4 million and bought 51% of VIZ Insurance for $1.484 million. Its profit rise received an $8.9 million boost from a tax accounting benefit, so cash generation gives a better view of progress. Locate Technologies posted its first quarterly profit as a listed company and generated NZ$828,000 of operating cash. Its immediate test is refinancing debt due before 7 November.

Contracts and capital remain central

RocketBoots has started installing its self-checkout software in US stores. It issued its first €84,445 invoice for cloud activation and initial sites. The wider rollout could support about A$9.1 million in yearly recurring revenue, but the customer will control the pace. RocketDNA raised $2.23 million for drone hardware, software, cyber-security approval and working capital. Its largest shareholder will increase his holding to 19.5%.

TZ Limited faces the clearest cash deadline. Its earlier shortfall share sale was not completed before it expired. Management changes and cost cuts could reduce employee and overhead expenses by about $1.6 million. The company still needs to secure money for its $1.3 million obligation. ION Video issued placement shares and free options, while directors are seeking approval for another issue at the 2026 annual meeting. These steps give the companies more cash or resources, but they also create more shares for investors to account for.

Bottom Line?

The next week will turn on evidence rather than plans. Investors will watch InFocus as it prepares for product testing and registration, RocketBoots as US installations expand, and Locate Technologies before its 7 November debt refinancing deadline. DorsaVi’s chip work remains tied to TSMC integration and partner evaluation, while TZ Limited must secure funding after its expired shortfall placement.

Questions in the middle?

  • Can InFocus complete registration and product testing before its early 2027 commercial target?
  • Will RocketBoots move from its first US installations to a broad rollout that supports about A$9.1 million in yearly recurring revenue?
  • Can TZ Limited secure the money due and turn its cost cuts into positive cash flow?

Sources

This wrap draws on announcements from 10 companies. For the full story and each verified source, see the company's own article:

ASX:DVL, ASX:HPG, ASX:IFG, ASX:IOV, ASX:NXL, ASX:ODA, ASX:RKT, ASX:ROC, ASX:TZL, NZX:LOC